Loading…
3 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 4,735 | 4,456 | 4,414 | 5,232 | 5,816 | 5,022 | 6,235 |
| EBITDA | 338 | 410 | 257 | 695 | 1,476 | 1,388 | 1,354 |
| Net profit | 354 | 214 | -44 | 525 | 1,419 | 1,258 | 1,027 |
| Total assets | 3,129 | 4,214 | 5,204 | 4,881 | 5,182 | 4,497 | 5,367 |
| n (companies reporting) | 2 | 3 | 3 | 3 | 3 | 2 | 2 |
GEL, thousands
| Company | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| Pardi Medikals | — | 0 | 1,616 | 1,867 | 2,862 | 3,240 | 4,511 |
| Lotusi | 2,600 | 2,480 | 1,703 | 1,857 | 1,646 | 1,782 | 1,724 |
| Shik Bebe | 2,135 | 1,976 | 1,096 | 1,507 | 1,309 | — | — |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Peer coverage varies by year — FY2018–FY2019, FY2023–FY2024 pool fewer than the 3 picked companies (see the n row). A year is never dropped because one peer is missing.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.